2 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow MOR103: new trials by email Literature Review of MOR103 trials Research Report on MOR103
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase Ib Study to Evaluate MOR103 in Multiple Sclerosis MOR103, Placebo - Multiple Sclerosis | Phase 1 / Phase 2 | Completed | MorphoSys AG | 32 | 2012-01-01 | 2014-11-21 |
| Safety and Preliminary Efficacy of MOR103 in Patients With Active Rheumatoid Arthritis MOR103 - Rheumatoid Arthritis | Phase 1 / Phase 2 | Completed | MorphoSys AG | 96 | 2009-12-01 | 2014-10-24 |
Arthritis, Rheumatoid (1) · Multiple Sclerosis (1)
MorphoSys AG (2)
Germany (2) · Poland (2) · Bulgaria (1) · Netherlands (1) · Ukraine (1) · United Kingdom (1)
Roman P Korolkiewicz, MD, PhD (2)